Submitted by admin on Fri, 2005-10-07 03:00. ::
PISCATAWAY, NJ, October 6, 2005 - Vladimir Badmaev, M.D., Ph.D., vice president of medical and scientific affairs at Sabinsa Corporation, will present "Clinical Experience with Standardized Herbals in Maintaining Lean Body Mass" at the 2005 WorldNutra Pre-Conference Symposium entitled Products and Ingredient Formulations for Weight Management and Wellness, on Sunday, October 16, 2005 at 2:15 p.m. at the Crowne Plaza Resort in Anaheim, Calif.
Dr. Badmaev will discuss the importance of lean body mass in healthy weight management, and highlight the role of ForsLean(R), a patented standardized extract of Coleus forskohlii roots, in increasing lean body mass and improving overall body composition. His session will highlight results from recently completed clinical studies, including one published in the August 2005 Journal of Obesity Research, which confirmed that ForsLean promotes favorable changes in body composition by significantly increasing lean body mass and decreasing body fat percentages. He will also cover ForsLean's mechanism of action, safety and toxicity and effect on key metabolic functions.
Dr. Badmaev is a noted speaker on this issue of the weight management, and recently presented at the World Obesity and Weight Loss Congress in Washington, D.C. He is responsible for managing all scientific studies and clinical trials involving Sabinsa's products. Dr. Badmaev studied medicine at the Medical Academy Bialystok (AMB) in Poland and received his M.D. in clinical and anatomical pathology from Kings County Hospital and Downstate Medical Center, New York, NY, in 1985. He also earned a Ph.D. in immunopharmacology from AMB in 1978. Dr. Badmaev is the author and coauthor of more than 30 scientific and popular scientific articles, four books and eight U.S. patents.
ForsLean is an extract derived from Coleus forskohlii roots, and the only known plant source of forskolin, a natural compound that has been shown to increase lean body mass and help optimize body composition through cAMP activation. Sabinsa holds U.S. Patent #5,804,596 and European Patent #98 907 537 9 for the use of forskolin as a weight management ingredient and manufactures and supplies various extract strengths for use in a variety of supplements and products. Other international patents are pending. For more information visit www.forslean.com .
This is cache, read story here
